The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review

Diabetologia

Volumn 58, Issue 7, 2015, Pages 1409-1421

  English, Emma ^a   Idris, Iskandar ^a   Smith, Georgina ^a   Dhatariya, Ketan ^b   Kilpatrick, Eric S ^c   John, W Garry ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Anaemia; Diabetes; HbA1c; Iron deficiency; Systematic review

Indexed keywords

ERYTHROCYTE PROTOPORPHYRIN; FERRITIN; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; IRON; TRANSFERRIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ANEMIA; DIABETES MELLITUS; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCATION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON THERAPY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MENOPAUSE; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PRIORITY JOURNAL; RETICULOCYTE; REVIEW; SYSTEMATIC REVIEW; TRANSFERRIN BLOOD LEVEL; ADULT; ANALYSIS; BLOOD; ERYTHROCYTE; FEMALE; PHYSIOLOGY; PREGNANCY; REPRODUCIBILITY;

ADULT; ANEMIA; ANEMIA, IRON-DEFICIENCY; BLOOD GLUCOSE; DIABETES MELLITUS; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PREGNANCY; REPRODUCIBILITY OF RESULTS;

EID: 84931563043     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3599-3     Document Type: Review

References (30)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986
2. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
3. Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364–1379
4. World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus (abbreviated report of a WHO consultation)
5. American Diabetes Association (2013) Standards of medical care in diabetes–2013. Diabetes Care 36(Suppl 1):S11–S66
6. John WG (2012) Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011. Diabet Med 29:1350–1357
7. United Nations Children’s Fund, United Nations University, World Health Organization (2001) Iron deficiency anaemia assessment, prevention, and control: a guide for programme managers. Available from www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf
8. Stevens GA, Finucane MM, De-Regil LM et al (2013) Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health 1:e16–25
9. Lowe G, Twaddle S (2005) The Scottish Intercollegiate Guidelines Network (SIGN): an update. Scot Med J 50:51–52
10. Consensus Committee (2007) Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 30:2399–2400
11. Hanas R, John G, International Hb ACC (2010) 2010 consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Clin Chem 56:1362–1364
12. Kim C, Bullard KM, Herman WH, Beckles GL (2010) Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999–2006. Diabetes Care 33:780–785
13. Ford ES, Cowie CC, Li C, Handelsman Y, Bloomgarden ZT (2011) Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US. J Diabetes 3:67–73
14. Hardikar PS, Joshi SM, Bhat DS et al (2012) Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young Indians partly explained by hematological factors and iron deficiency anemia. Diabetes Care 35:797–802
15. Son JI, Rhee SY, Woo JT et al (2013) Hemoglobin A1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects. Diabetes Metab J 37:343–348
16. Shanthi B, Revathy C, Manjula Devi AJ, Subhashree (2013) Effect of iron deficiency on glycation of haemoglobin in nondiabetics. J Clin Diagn Res 7:15–17
17. Coban E, Ozdogan M, Timuragaoglu A (2004) Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 112:126–128
18. El-Agouza I, Abu Shahla A, Sirdah M (2002) The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis. Clin Lab Haematol 24:285–289
19. Gram-Hansen P, Eriksen J, Mourits-Andersen T, Olesen L (1990) Glycosylated haemoglobin (HbA1c) in iron- and vitamin B12 deficiency. J Intern Med 227:133–136
20. Sinha N, Mishra TK, Singh T, Gupta N (2012) Effect of iron deficiency anemia on hemoglobin A1c levels. Ann Lab Med 32:17–22
21. Behan KJ (2006) Cessation of menstruation improves the correlation of FPG to hemoglobin A1c in Caucasian women. Clin Lab Sci 19:225–230
22. Koga M, Morita S, Saito H, Mukai M, Kasayama S (2007) Association of erythrocyte indices with glycated haemoglobin in pre-menopausal women. Diabet Med 24:843–847
23. Koga M, Saito H, Mukai M, Matsumoto S, Kasayama S (2010) Influence of iron metabolism indices on glycated haemoglobin but not glycated albumin levels in premenopausal women. Acta Diabetol 47(Suppl 1):S65–S69
24. Selvin E, Parrinello CM, Sacks DB, Coresh J (2014) Trends in prevalence and control of diabetes in the United States, 1988–1994 and 1999–2010. Ann Intern Med 160:517–525
25. Mainous AG 3rd, Tanner RJ, Baker R, Zayas CE, Harle CA (2014) Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study. BMJ Open 4:e005002
26. Raj S, Rajan GV (2013) Correlation between elevated serum ferritin and HbA1c in type 2 diabetes mellitus. Int J Res Med Sci 1:12–15
27. Cohen RM, Franco RS, Khera PK et al (2008) Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 112:4284–4291
28. Hoelzel W, Weykamp C, Jeppsson JO et al (2004) IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174
29. Jeppsson JO, Kobold U, Barr J et al (2002) Approved IFCC reference method for the measurement of HbA(1c) in human blood. Clin Chem Lab Med 40:78–89
30. Weykamp C, John WG, Mosca A et al (2008) The IFCC Reference Measurement System for HbA1c: a 6-year progress report. Clin Chem 54:240–248